Study examines use of bevacizumab among patients with hereditary blood vessel disorder
In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received ...
Diseases, Conditions, Syndromes
Mar 06, 2012 |
not rated yet |
0
Using patients' own tumor-fighting cells to knock back advanced melanoma
A small, early-phase clinical trial to test the effectiveness of treating patients with advanced melanoma using billions of clones of their own tumor-fighting cells combined with a specific type of chemotherapy has shown ...
Cancer
Mar 05, 2012 |
4.8 / 5 (5) |
0
|
Vandetanib doesn't up survival in non-small-cell lung cancer
(HealthDay) -- Vandetanib does not improve overall survival for patients who have received previous treatment for advanced non-small-cell lung cancer (NSCLC), according to a study published online Feb. 27 ...
Cancer
Mar 02, 2012 |
not rated yet |
0
No workout? No worries: Scientists prevent muscle loss in mice, despite disease and inactivity
If you want big muscles without working out, there's hope. In the March 2012 print issue of the FASEB Journal, scientists from the University of Florida report that a family of protein transcription factors, called "Forkhead (F ...
Medical research
Feb 29, 2012 |
4.8 / 5 (5) |
0
|
Device designed to treat a leading cause of blindness
(Medical Xpress) -- Every year, more than 200,000 people in the U.S. are diagnosed with Wet Age-Related Macular Degeneration, a leading cause of blindness in Americans age 60 or older. There is no known cure ...
Ophthalmology
Feb 29, 2012 |
5 / 5 (3) |
0
High VEGF signaling score tied to lung cancer prognosis
(HealthDay) -- A high vascular endothelial growth factor (VEGF) signaling score correlates with good prognosis in patients with early squamous cell carcinoma (SCC) of the lung, according to a study published ...
Cancer
Feb 22, 2012 |
5 / 5 (1) |
0
New ability to regrow blood vessels holds promise for treatment of heart disease
(Medical Xpress) -- University of Texas at Austin researchers have demonstrated a new and more effective method for regrowing blood vessels in the heart and limbs — a research advancement that could have ...
Medical research
Feb 13, 2012 |
5 / 5 (6) |
4
|
Smallest tools could give biggest results in bone repair
When William Murphy works with some of the most powerful tools in biology, he thinks about making tools that can fit together. These constructions sound a bit like socket wrenches, which can be assembled to turn a half-inch ...
Medical research
Feb 06, 2012 |
not rated yet |
0
Discovery predicts patient sensitivity to important drug target in deadly brain cancer
A recent discovery by Van Andel Research Institute (VARI) scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma – the most common and most aggressive malignant brain tumor ...
Cancer
Feb 06, 2012 |
4 / 5 (2) |
0
|
Three 'targeted' cancer drugs raise risk of fatal side effects
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that ...
Cancer
Feb 06, 2012 |
5 / 5 (1) |
0
|
Exercise triggers stem cells in muscle
University of Illinois researchers determined that an adult stem cell present in muscle is responsive to exercise, a discovery that may provide a link between exercise and muscle health. The findings could lead to new therapeutic ...
Medical research
Feb 06, 2012 |
4.7 / 5 (6) |
0
|
New drug doesn't improve disability among stroke patients
A new drug that showed promise in animal studies and an early clinical trial didn't improve disability among stroke patients, according to late-breaking research presented at the American Stroke Association's International ...
Cardiology
Feb 03, 2012 |
not rated yet |
0
A thought-provoking new therapeutic target for brain cancer?
Glioblastoma multiforme (GBM) is the most common of all malignant brain tumors that originate in the brain. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant ...
Cancer
Feb 01, 2012 |
not rated yet |
0
Report shows risk of blindness halved over last decade
Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World. A report from the University of Copenhagen and Glostrup Hospital in Denmark published today shows the number of new cases ...
Ophthalmology
Jan 19, 2012 |
not rated yet |
0
The link between TB and a gene mutation that causes lung cancer
Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease ...
Cancer
Jan 18, 2012 |
not rated yet |
0
